148 related articles for article (PubMed ID: 36777747)
21. Single-Day Low-Residue Diet Prior to Colonoscopy Demonstrates Improved Bowel Preparation Quality and Patient Tolerance over Clear Liquid Diet: A Randomized, Single-Blinded, Dual-Center Trial.
Samarasena JB; El Hage Chehade N; Abadir A; Yu A; Tran E; Mai D; Thieu D; Albers G; Parekh NK; Karnes WE; Chang K; Jamal MM
Dig Dis Sci; 2022 Jun; 67(6):2358-2366. PubMed ID: 34114154
[TBL] [Abstract][Full Text] [Related]
22. Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil.
Sassaki LY; Miszputen SJ; Kaiser Junior RL; Catapani WR; Bafutto M; Scotton AS; Zaltman C; Baima JP; Ramos HS; Faria MAG; Gonçalves CD; Guimaraes IM; Flores C; Amarante HMBS; Nones RB; Parente JML; Lima MM; Chebli JM; Ferrari MLA; Campos JF; Sanna MGP; Ramos O; Parra RS; da Rocha JJR; Feres O; Feitosa MR; Caratin RF; Senra JT; Santana GO
World J Gastroenterol; 2021 Jun; 27(23):3396-3412. PubMed ID: 34163120
[TBL] [Abstract][Full Text] [Related]
23. Bisacodyl plus split 2-L polyethylene glycol-citrate-simethicone improves quality of bowel preparation before screening colonoscopy.
Valiante F; Bellumat A; De Bona M; De Boni M
World J Gastroenterol; 2013 Sep; 19(33):5493-9. PubMed ID: 24023492
[TBL] [Abstract][Full Text] [Related]
24. Efficacy, Tolerability, and Safety of Low-Volume Bowel Preparations for Patients with Inflammatory Bowel Diseases: The French Multicentre CLEAN Study.
Briot C; Faure P; Parmentier AL; Nachury M; Trang C; Viennot S; Altwegg R; Bulois P; Thomassin L; Serrero M; Ah-Soune P; Gilletta C; Plastaras L; Simon M; Dray X; Caillo L; Del Tedesco E; Abitbol V; Zallot C; Degand T; Rossi V; Bonnaud G; Colin D; Morel B; Winkfield B; Danset JB; Filippi J; Amiot A; Attar A; Levy J; Peyrin-Biroulet L; Vuitton L;
J Crohns Colitis; 2019 Sep; 13(9):1121-1130. PubMed ID: 30785181
[TBL] [Abstract][Full Text] [Related]
25. TWEAK is not elevated in patients with newly diagnosed inflammatory bowel disease.
Grimstad T; Skoie IM; Doerner J; Isaksen K; Karlsen L; Aabakken L; Omdal R; Putterman C
Scand J Gastroenterol; 2017 Apr; 52(4):420-424. PubMed ID: 28040992
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of 4 L, 2 L, and 1 L PEG bowel preparation for colonoscopy in patients with ulcerative colitis: a retrospective study.
Dai C; Tian W; Huang YH; Jiang M
Rev Esp Enferm Dig; 2023 Oct; ():. PubMed ID: 37882178
[TBL] [Abstract][Full Text] [Related]
27. Bowel preparation using 2-L split-dose polyethylene glycol regimen plus lubiprostone versus 4-L split-dose polyethylene glycol regimen: a randomized controlled trial.
Sirinawasatien A; Sakulthongthawin P; Chanpiwat K; Chantarojanasiri T
BMC Gastroenterol; 2022 Sep; 22(1):424. PubMed ID: 36115968
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and tolerability of polyethylene glycol-electrolyte lavage solution with and without simethicone in the preparation of patients with inflammatory bowel disease for colonoscopy.
Lazzaroni M; Petrillo M; Desideri S; Bianchi Porro G
Aliment Pharmacol Ther; 1993 Dec; 7(6):655-9. PubMed ID: 8161673
[TBL] [Abstract][Full Text] [Related]
29. Rates and characteristics of postcolonoscopy colorectal cancer in the Swedish IBD population: what are the differences from a non-IBD population?
Stjärngrim J; Ekbom A; Hammar U; Hultcrantz R; Forsberg AM
Gut; 2019 Sep; 68(9):1588-1596. PubMed ID: 30554159
[TBL] [Abstract][Full Text] [Related]
30. Multi-step validation of a deep learning-based system for the quantification of bowel preparation: a prospective, observational study.
Zhou W; Yao L; Wu H; Zheng B; Hu S; Zhang L; Li X; He C; Wang Z; Li Y; Huang C; Guo M; Zhang X; Zhu Q; Wu L; Deng Y; Zhang J; Tan W; Li C; Zhang C; Gong R; Du H; Zhou J; Sharma P; Yu H
Lancet Digit Health; 2021 Nov; 3(11):e697-e706. PubMed ID: 34538736
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
32. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
[TBL] [Abstract][Full Text] [Related]
33. Serum adipokines in inflammatory bowel disease.
Waluga M; Hartleb M; Boryczka G; Kukla M; Zwirska-Korczala K
World J Gastroenterol; 2014 Jun; 20(22):6912-7. PubMed ID: 24944482
[TBL] [Abstract][Full Text] [Related]
34. Awareness and Compliance with the Recommendations of Primary and Secondary Prevention of Cancer in Patients with Inflammatory Bowel Disease.
Tulewicz-Marti E; Stępień-Wrochna B; Maciejewska K; Łodyga M; Karłowicz K; Lewandowski K; Rydzewska G
J Pers Med; 2023 May; 13(6):. PubMed ID: 37373902
[TBL] [Abstract][Full Text] [Related]
35. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience.
Kiran RP; Khoury W; Church JM; Lavery IC; Fazio VW; Remzi FH
Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662
[TBL] [Abstract][Full Text] [Related]
36. Correlation of clinical and endoscopic indices in IBD patients in University Clinical Hospital Mostar.
Babić E; Bevanda M; Karin M; Volarić M; Bevanda D; Glibo DB; Bogut A
Psychiatr Danub; 2016 Dec; 28 Suppl 2():242-246. PubMed ID: 28035129
[TBL] [Abstract][Full Text] [Related]
37. Split-dosed MiraLAX/Gatorade is an effective, safe, and tolerable option for bowel preparation in low-risk patients: a randomized controlled study.
Samarasena JB; Muthusamy VR; Jamal MM
Am J Gastroenterol; 2012 Jul; 107(7):1036-42. PubMed ID: 22565162
[TBL] [Abstract][Full Text] [Related]
38. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
[TBL] [Abstract][Full Text] [Related]
39. Anxiety is associated with impaired tolerance of colonoscopy preparation in inflammatory bowel disease and controls.
Bessissow T; Van Keerberghen CA; Van Oudenhove L; Ferrante M; Vermeire S; Rutgeerts P; Van Assche G
J Crohns Colitis; 2013 Dec; 7(11):e580-7. PubMed ID: 23664621
[TBL] [Abstract][Full Text] [Related]
40. Colon Cleansing for Colonoscopy in Patients with Ulcerative Colitis: Efficacy and Acceptability of a 2-L PEG Plus Bisacodyl Versus 4-L PEG.
Manes G; Fontana P; de Nucci G; Radaelli F; Hassan C; Ardizzone S
Inflamm Bowel Dis; 2015 Sep; 21(9):2137-44. PubMed ID: 26164666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
